Search

Search Results
Results 2311 - 2320 of 8492 for Skin Cancer
  • Drug - 31 Oct 2025
    Consumer Medicine Information (CMI) about Giotrif intended for persons living in Australia.
  • Drug - 9 Oct 2025
    Consumer Medicine Information (CMI) about Cabometyx intended for persons living in Australia.
  • Drug - 3 Oct 2025
    Consumer Medicine Information (CMI) about DBL Docetaxel intended for persons living in Australia.
  • News - 14 Aug 2025
    Over the past 20 years, a class of cancer drugs called CD40 agonist antibodies have shown great promise-and induced great disappointment.
  • News - 22 Jun 2025
    Scientists identified 473 human genes that act as genetic “on/off switches,” shaping disease risk through tissue-specific or universal patterns regulated by DNA changes and hormones. These findings...
  • News - 26 Apr 2025
    Senescent skin cells, often referred to as zombie cells because they have outlived their usefulness without ever quite dying, have existed in the human body as a seeming paradox, causing inflammation...
  • Drug - 21 Feb 2025
    Consumer Medicine Information (CMI) about Methoblastin intended for persons living in Australia.
  • Drug - 21 Feb 2025
    Consumer Medicine Information (CMI) about Methoblastin Blister intended for persons living in Australia.
  • Health - 13 Feb 2025
    This article details the punch biopsy procedure, a key diagnostic tool for dermatologists to assess suspicious skin lesions and inflammatory conditions.
  • News - 3 Feb 2025
    Melanoma is a fast-progressing skin cancer characterized by a high mortality rate after metastasis. Local chemotherapy could be considered a therapeutic approach only in stage 0 of progression (in...

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.